Article | Open

# Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer

• Scientific Reports 7, Article number: 7833 (2017)
• doi:10.1038/s41598-017-07947-6
Accepted:
Published online:

## Abstract

Hypoxia modulates actin organization via multiple pathways. Analyzing the effect of hypoxia on the biophysical properties of cancer cells is beneficial for studying modulatory signalling pathways by quantifying cytoskeleton rearrangements. We have characterized the biophysical properties of human LNCaP prostate cancer cells that occur in response to loss of the retinoblastoma protein (Rb) under hypoxic stress using an oscillating optical tweezer. Hypoxia and Rb-loss increased cell stiffness in a fashion that was dependent on activation of the extracellular signal-regulated kinase (ERK) and the protein kinase B (AKT)- mammalian target of rapamycin (MTOR) pathways. Pharmacological inhibition of MEK1/2, AKT or MTOR impeded hypoxia-inducible changes in the actin cytoskeleton and inhibited cell migration in Rb-deficient cells conditioned with hypoxia. These results suggest that loss of Rb in transformed hypoxic cancer cells affects MEK1/2-ERK/AKT-MTOR signalling and promotes motility. Thus, the mechanical characterization of cancer cells using an optical tweezer provides an additional technique for cancer diagnosis/prognosis and evaluating therapeutic performance.

## Introduction

In cancer and in particular, the tumour microenvironment, hypoxia is a pathological condition in which a significant region of the tumour is deprived of oxygen and is associated with increased risk of metastasis1, 2. Invasion and metastasis are complex and life threatening processes that transform anchored cells into mobile cells. Structural remodeling of the actin cytoskeleton is a critical component in most cancer cells for invasion and metastasis3. Recent studies on the effect of hypoxia on cell function revealed new information about the relationship between hypoxia and actin protein alterations that underlies the invasive cancer cell phenotype4,5,6,7. Modulation of actin organization under hypoxic conditions is complex and multiple pathways contribute to their alteration, such as Rho signalling pathways, the SCAP/SREBP1 pathway, MTOR phosphorylation pathways, p38 MAP kinase activation and HSP27 phosphorylation8,9,10,11,12. Elucidating different modulatory signalling pathways that alter actin organization and mediate the invasive cancer cell phenotype may prove a useful avenue for the development of novel anti-cancer therapeutic agents.

The hypoxic signal mediated by the HIF-1α-ARNT/HIF-1β transcriptional complex13 induces expression of genes associated with advanced stages of tumour growth and metastasis14,15,16. The retinoblastoma protein (Rb) is a tumour suppressor protein that is associated with the HIF-1α-ARNT-TRIP230 transcriptional complex and is a key regulator of the hypoxic response13. TRIP230 is an essential regulator of the hypoxic response17 and recruits Rb to HIF-1 target genes18. Subsequently, loss of Rb function results in biochemical changes that promote invasiveness in cancer cells16, 18.

Studying different signalling pathways that modulate actin organization under hypoxia is possible via analyzing the biophysical properties of cancer cells and quantifying cytoskeleton rearrangement19. Extracellular signal-related kinase (ERK) and protein kinase B (AKT) signalling pathways are important intracellular regulators of cell growth, proliferation, and malignant transformation20. Mitogen-activated protein kinase kinase -1 (MAPKK1 also known as MEK1) and MEK2 are tyrosine/threonine kinases that phosphorylate and activate ERK1/2 proteins21. The MEK1/2-ERK pathway plays an important role in actin organization and it can cause increases in cell motility and invasiveness by directly targeting actin proteins22. Moreover, AKT signalling can influence cell migration by modulating actin reorganization in the cell23. Additionally, MTOR signalling pathways control actin organization and regulates tumour cell invasion and motility24. MTOR is part of two distinct complexes. MTORC1 is known to regulate cellular proliferation and cell survival while MTORC2 modulates cytoskeleton reorganization through a direct effect on AKT25. Furthermore, the hypoxic signal mediated by the HIF-1α-ARNT transcriptional complex also causes expression of genes associated with tumour growth and metastasis. Gene ontogeny suggests that the Rb-HIF1 complex mediates the ERK1/2, AKT and NFκB signalling pathways, and therefore, perturbations in Rb expression may result in actin impairment and reorganization16.

Here we report cytoskeletal changes in human LNCaP prostate cancer cells that occur in response to loss of Rb under hypoxic stress using an oscillating optical tweezer (OT). The oscillating OT is an instrument that uses a highly focused laser beam to trap and oscillate a microbead attached to the cell cytoskeleton and therefore, exert a quantifiable force on the cell. The technical details of our setup have been described previously26. In summary, a continuous wave 3 W, Nd:YAG laser emitting light at a wavelength of 1064 nm was used with a Nikon TE2000 inverted microscope. A CCD camera and a CMOS camera were utilized to monitor the experimental process and to track the motion of the bead, respectively. LNCaP cells were selected as we have shown previously that hypoxia conditioned Rb-knockdown cells are capable of undergoing neuroendocrine differentiation (NED) and adopting an invasive phenotype16. Furthermore, interrogation of the LNCaP transcriptome identified the top up- and down-regulated genes sensitive to Rb-loss and hypoxia involved in metastasis and NED16. Nevertheless, we know little about actin structural changes and motile properties or the pathways that induce the invasive phenotype of Rb-deficient LNCaP cells. In order to quantify the cytoskeletal remodelling and stiffness of control and Rb-depleted LNCaP cells, movement of microbeads that bind to cell surface integrin receptors using an OT were measured and validated.

## Results

### Loss of Rb alters the mechanical properties of hypoxic LNCaP cells

The measured bead displacements for each group of cells after exposure to 72 h of hypoxia or normoxia, along with the solution of the bead motion equation were used to identify viscoelastic properties of the cells26. The viscoelastic properties of the cell include shear modulus and viscosity coefficient. These parameters are measures of cell stiffness. More specifically, the shear modulus describes the elastic behavior of the cell cytoskeleton proteins and it is correlated with the distribution of the cell cytoskeletal proteins. The viscosity coefficient is associated with the viscose components of cells, such as cell cytoplasm. According to our results (Fig. 1D), shear modulus alterations for each group of cells were frequency dependent with a weak power-law dependency. Comparing the shear modulus at all applied frequencies of 0.1 Hz, 1 Hz, and 10 Hz, there exists a significant difference between hypoxia treated shRb cells and all other groups of cells. Both cell groups (shRb and shSCX) under hypoxia demonstrated an increase in shear modulus compared to normoxic cells, while the shRb group of cells showed the most significant increase in cell shear modulus at all frequencies (Fig. 1D). The viscosity coefficient response was not frequency dependent; however, there was a significant difference between the hypoxic shRb cells and all other treatments (Fig. 1E). In addition, the difference between normoxic shSCX cells and hypoxic shSCX cells was not significant. Finally, the viscosity coefficient was increased for the hypoxic conditioned cells compared to the cells cultured in normoxia. The power-law coefficient, which is an intrinsic cytoskeletal property, decreased under hypoxia for both shRb and shSCX cells compared to their normoxic conditioned cells. Thus, our results suggest that hypoxia alters the mechanical properties of Rb-deficient cells, which may be observed as measurable changes in the molecular organization of the cell cortex.

To further assess the effect of hypoxia and Rb-loss on the organization of the LNCaP cytoskeleton, we measured the relaxation time of control and Rb-depleted cells by monitoring the random movement of trapped beads anchored to the cell cytoskeleton34. More details about the derivation of relaxation time are presented in the data analysis section of the Materials and Methods. The normalized position autocorrelation function (NPAF) of bead movement for the different groups of cells was plotted in Fig. 2A. The NPAF results were analyzed by fitting with exponential functions. According to these results, the time scale varied for different groups of cells; however, cells under hypoxic stress demonstrated a higher relaxation time compared to normoxic cells and hypoxic shRb cells had a significantly higher relaxation time compared to all other conditions (Fig. 2B). Moreover, the cell viscosity coefficient was derived based on the relaxation times and showed a significant increase between the hypoxia conditioned shRb cells and all other groups of cells (Fig. 2C). Accordingly, these findings are in agreement with our previous results and suggest that structural changes are occurring within the cell.

### The cell stiffness response and cytoskeleton alterations are dependent on ERK, AKT and MTOR

Next we wanted to determine the pathway responsible for the observed increase in cell stiffness. Gene ontology analysis of the LNCaP transcriptome identified the MEK1/2-ERK1/2 pathway as a likely regulator of hypoxia-inducible cell motility in Rb-knockdown cells16. In order to determine if the MEK1/2-ERK1/2 pathway is responsible for changes in actin distribution, shRNA LNCaP cells were treated with vehicle or 10 μM of the MEK1/2 inhibitor U0126 and then conditioned with either normoxia or hypoxia. Cell mechanical properties were determined by applying time varying force on beads anchored to the cytoskeleton, employing the OT and measuring bead displacement. The Rb-depleted (shRb) cells under hypoxic stress showed a significant increase in shear modulus compared to the scrambled negative control (shSCX) cells (Fig. 3A). While there were no significant differences between shSCX or shRb cells maintained under normoxia and treated with or without U0126, hypoxic shRb cells treated with U0126 demonstrated a significantly lower shear modulus compared to untreated hypoxic shRb cells (Fig. 3A). Likewise, hypoxia conditioned shRb cells demonstrated a significant increase in cell viscosity compared to normoxic cells and hypoxic shSCX cells, however, this effect disappeared with the addition of 10 μM U0126 (Fig. 3B). Immunoblots of whole cell lysates determined that both shSCX and shRb LNCaP cells conditioned with hypoxia expressed elevated levels of phosphorylated ERK1/2 protein, a bona fide marker of the hypoxic response35, 36. Importantly, addition of 10 μM U0126 blocked ERK1/2 phosphorylation (Fig. 3C). These results suggest that hypoxia increased cell stiffness in Rb knockdown cells in an ERK-dependent fashion. Inhibition of the MEK1/2-ERK pathway using U0126 inhibited the alterations in actin structure, which was observed as decreased cell shear modulus. Furthermore, we studied the effect of the NFκB pathway on actin disruption by treating cells with 15 μM of wedelolactone; an NFκB inhibitor that blocks the phosphorylation and degradation of IκBα. The mechanical responses of the cells were again calculated upon applying time varying force on beads adhered to LNCaP cells using the OT and measuring bead displacement. The result showed no significant differences between cells treated with or without wedelolactone (Fig. 3D and E). Thus, NFκB does not play a role in altered cell stiffness of Rb knockdown LNCaP cells in response to hypoxia.

In order to further characterize our results, we examined the role of AKT, a regulator of actin organization that works in parallel and cross-talks with the ERK1/2 signalling pathway37, 38. We maintained shRNA LNCaP cells in either normoxia or hypoxia and treated cells with or without 2 μM A6730, an inhibitor of AKT. Interestingly, we found that inhibiting AKT phosphorylation produced alterations in cell shear modulus similar to inhibiting ERK phosphorylation (Fig. 4A and B). Immunoblots of total cell lysates using an affinity purified antibody specific for total and phosphorylated AKT demonstrated that shRb cells cultured in hypoxic conditions had higher levels of phosphorylated AKT compared to all other groups of cells and that AKT phosphorylation was prevented by treatment with A6730 (Fig. 4C). Moreover, we determined the role that MTOR might play in this phenomenon. MTOR is a downstream effector of the AKT and MEK-ERK pathways and a regulator of actin organization39, 40. The shear modulus and viscosity of LNCaP cells treated with or without 10 nM INK128, a specific inhibitor of MTOR, and incubated under normoxic or hypoxic conditions were measured (Fig. 4D and E). We observed a significant increase in the shear modulus of untreated hypoxic Rb knockdown cells. This condition was reversed with INK128 treatment, which is in agreement with our observations using A6730 and U0126. Thus, our results demonstrate that both MEK-ERK-MTOR and AKT-MTOR signalling pathways are responsible for the changes in the mechanical properties we observed in Rb-depleted hypoxic LNCaP cells.

As previously stated, changes in normalized amplitude of resultant bead movement (NARBM) in response to the OT applied force is an indication of cytoskeletal remodelling27,28,29,30. However, we wanted to confirm that the changes in cell viscoelastic properties that we observed in Rb-deficient LNCaP cells led to actin reorganization. Thus, we performed immunofluorescence microscopy using rhodamine phalloidin as an actin probe on shRNA LNCaP cells conditioned with either hypoxia or normoxia and treated with or without U0126 or A6730 (Fig. 5). Both normoxic shSCX and normoxic shRb cells displayed a typical LNCaP phenotype with an elongated cell structure, a rather even distribution of actin fluorescence and the presence of well-defined cell-cell boundaries (Fig. 5, 1st row, thin white arrows point to cell-cell boundaries). Rb-knockdown cells exposed to hypoxia demonstrated altered actin distribution compared to normoxic cells and profound morphological changes were observed (Fig. 5, right-hand panels, fourth row). Actin fluorescence in shRb hypoxic cells seemed to diminish along cell-cell boundaries and concentrate in distinct filopodia-like clusters along the cell periphery (Fig. 5, right-hand panels, fourth row, large white arrowheads point to filopodia-like clusters) a common feature of metastatic transformation41. To a lesser degree, some hypoxic control cells seemed to also undergo distinct morphological changes and some actin redistribution but the majority of cells retained their elongated phenotype with rather more distinct and uniform actin distribution along the cell border (Fig. 5, left-hand panels, fourth row, thin white arrows point to cell-cell boundaries). In addition, a double-blind analysis using ImageJ software to characterize cell-cell boundaries and filopodia-like processes determined significant phenotypic differences between hypoxic shRb cells and all other conditions (Table 1). Specifically, a Kruskall-Wallis analysis with Dunn’s multiple comparisons test (alpha = 0.05; P-value < 0.05) determined that the average pixel intensity in cell-cell boundaries was significantly lower in hypoxic shRb cells (64.16 ± 19.10) compared to hypoxic shSCX cells (93.57 ± 26.78) and to normoxic shSCX (91.44 ± 31.19) and shRb cells (84.54 ± 31.11) suggesting a redistribution of actin away from cell-cell boundaries in hypoxic shRb cells (Fig. 6A). Importantly, a two-sided Fisher’s exact test determined that the proportion of cells with filopodia-like clusters was significantly different between hypoxic shRb cells and hypoxic shSCX cells, 0.59 and 0.38 respectively with P-value = 0.0065 (Fig. 6B). Furthermore, the proportion of cells with filopodia-like processes was also significantly different between hypoxic shRb cells and normoxic controls with P-value < 0.0001. Although the proportion of hypoxic shRb cells displaying filopodia-like clusters was significantly different compared to the other treatments, quantifying the number of filopodia and average amount of actin in the filopodia-like clusters was too difficult to parse out as the areas of defined clusters varied widely within the cell populations making the standard deviations of quantified measurements too large for statistical significance (Fig. 6C, Table 1 and Supplementary Dataset Files 1 and 2). Nevertheless, our morphological analysis supports the results we obtained from our mechanical characterization studies and suggests that Rb-loss significantly changes the organization of actin in hypoxic LNCaP cells. Raw values for all our measurements can be found in Supplementary Dataset File 1 and summaries of our analyses can be found in Supplementary Dataset File 2.

Interestingly, pre-treatment of cells with either 10 μM U0126 or 2 μM A6730 impeded the hypoxia-inducible alterations in cellular morphology and redistribution of actin fluorescence in the shRb cells (Fig. 5). Indeed, treatment with A6730 and to a lesser extent with U0126 significantly reduced the proportion of cells exhibiting filopodia-like clusters in hypoxic shRb cells and inhibited the morphological changes promoted by hypoxia and Rb-loss (Fig. 6D and Supplementary Dataset Files 1 and 2). Finally, immunoblots of total cell lysates revealed that the dramatic cytoskeletal changes in shRb cells conditioned with hypoxia was not due to altered actin levels (Fig. 7A). Taken together, these results demonstrate that both the AKT and MEK1/2-ERK1/2 pathways play a critical role in hypoxia-inducible alterations of the actin cytoskeleton in Rb-deficient LNCaP cells. In addition, changes in cell stiffness response measured by the OT correlate with changes in actin remodelling.

### Hypoxia inducible migration is dependent on ERK, AKT and MTOR

A growing body of evidence in the literature23, 42 suggest that the AKT and ERK signalling pathways control cell migration. Furthermore, gene ontology analysis16 suggests that Rb is linked to this process in hypoxic LNCaP cells. To determine if actin reorganization correlates with increased cell migration, we conditioned shRNA LNCaP cells with hypoxia or normoxia and used a cell migration assay to measure the total number of migrating cells. Indeed, shRb LNCaP cells exposed to hypoxia migrated at a significantly higher rate compared to scrambled negative controls and to normoxic shRb cells (Fig. 7B). Additionally, treatment with 10 μM U0126, 2 μM A6730 or 10 nM INK128 significantly impeded hypoxia-inducible migration in shRb LNCaP cells compared to the untreated control (Fig. 7C). Taken together, these data support our hypothesis that the ERK1/2 and AKT pathways may crosstalk through MTOR to control migration and invasion in hypoxic prostate cancer cells lacking Rb. Moreover, in our study, the cell migration data correlates with the OT data. In the future, we will investigate if OT measurements could be used to predict migratory cell phenotypes in a more general fashion.

## Discussion

In this study we examined the hypoxia-inducible changes in biophysical properties of control and Rb-knockdown LNCaP prostate cancer cells using an oscillating OT. Our results indicate that loss of Rb protein in prostate cancer cells under hypoxic conditions increases migration and alters cytoskeletal protein dynamics by activating the downstream signalling modules. The over-activity of either the ERK1/2 or AKT pathways facilitates alterations in the cytoskeleton that promote motility and result in structural changes and actin protein redistribution without altering the level of total actin in the cell or by increasing mRNA levels of actin-associated integrins. These alterations correlated with changes in cell stiffness that were estimated by measuring the resultant movement of beads (NARBM) anchored to the cytoskeleton. Changes in bead movement correspond to changes in cell stiffness and in turn, actin organization, where decreased movement is likely a result of redistribution and stabilization of actin and/or an increase in cell tethering forces at focal adhesion sites either on the bead or on the cell substrate32. This increase in cortical stiffness at focal adhesion sites might translate into increased migratory capacity of the cell via a leader-bleb mechanism43. Furthermore, inhibition of either the ERK1/2 or AKT-MTOR pathways prevented actin reorganization that may contribute to cancer cell transformation and motility. In order to analyze alterations in the mechanical properties of control and Rb-knockdown LNCaP cells, resultant bead movements were measured under hypoxic and normoxic conditions using an oscillating OT26. The results show time dependent changes in bead movement for cells (shSCX and shRb) cultured under hypoxia for 72 h. In addition, increased cell migration in hypoxic shRb LNCaP cells suggests that there is a correlation between increased cell migration and actin reorganization.

Activation of the ERK1/2 pathway has a profound effect on actin disruption in many cell types44,45,46,47,48; however, these findings were mainly based on structural evidence. Consistent with these structural observations, we measured and analyzed cell mechanical properties and investigated the role of the ERK pathway on actin reorganization. Based on our results, the parallel activation of both the MEK1/2-ERK and AKT pathways are responsible for actin reorganization and morphological changes in Rb-deficient hypoxic cancer cell lines. Inhibition of either the MEK1/2-ERK or AKT pathways using U0126 or A6730, respectively prevented or impeded the development of actin-containing filopodia and inhibition of other hypoxia-induced morphological changes in Rb-ablated LNCaP cells (Fig. 5). Moreover, we measured alterations in cell mechanical properties after inhibiting MTOR, the downstream effector of the AKT and MEK-ERK pathways. Inhibition of the MTOR pathway phenocopied inhibition of the MEK-ERK or AKT pathways, suggesting that MTOR is a downstream effector of both the MEK-ERK and AKT pathways for actin reorganization in Rb-depleted hypoxic cancer cell lines. Additionally, other HIF1-regulated pathways may be sensitive to loss of Rb and contribute to this phenotype. Activation of focal adhesion kinase and phosphorylation of paxillin correlate with hypoxia-inducible migration of C6 glioma cells49. Up-regulation of vimentin intermediary filaments has been implicated in epithelial-to-mesenchymal transition and increased migratory capacity in lung cancer cells in an AKT-dependent fashion50. However, hypoxia-induced reorganization of filamentous actin is concomitant with vimentin condensation in an ERK-dependent fashion51. The relative contribution of actin and vimentin reorganization to the migratory capacity of the cell should be resolved using RNA knockdown technologies.

The evidence presented here suggests that loss of Rb in hypoxic prostate cancer cells increases actin reorganization and migration through ERK-AKT-MTOR signalling (Fig. 8). Several studies have demonstrated crosstalk between PI3K-AKT-MTOR and MEK-ERK signalling pathways52,53,54. However, depending on the stimulus, the pathways may have cooperative, inhibitory or separate biological functions. For example, MEK1, MEK2 and MEK5 inhibitors enhance AKT activation possibly involving phosphorylation of GAB1 induced by ERK2 and inhibition of recruitment of PI3K to the EGF receptor55. Alternatively, it has been reported that AKT can phosphorylate inhibitory sites in Raf, and consequently down regulate ERK1/256. Conversely, cross-activation has also been reported. In this instance, Ras-ERK regulates PI3K, and MTORC1 which results in cross activation of PI3K-MTORC157. Furthermore, the ERK1/2 and AKT promote MTORC1 activity by inhibiting TSC1/2’s GAP function58.

Previously, we determined that loss of Rb dysregulates HIF1-mediated transcriptional responses18 and that Rb-loss in conjunction with hypoxia leads to the acquisition of a more invasive and neuroendocrine phenotype in prostate cancer cells16. We identified several putative upstream regulators of ERK1/2 and AKT-MTOR signalling that may contribute to prostate cancer cell transformation, such as CXCR4, HTR5A and KISS1 receptor (KISS1R)16. Furthermore, loss of Rb expression and hypoxia sensitized prostate cancer cells to kisspeptin-10, a potent KISS1R agonist16. Although KISS1/KISS1R interactions have been linked to both pro- and anti-metastatic processes, KISS1R expression in breast cancer cells increases cell invasion and metastasis59, 60. Additionally, KISS1R signalling activates ERK1/2 through β-arrestin61 and stimulates invadopodia formation in triple negative breast cancer via β-arrestin and ERK1/2-dependent mechanisms62. The KISS1R-ERK1/2-invadopodia paradigm requires further investigation in prostate cancer, however, we speculate that some Rb-negative prostate cancer cells under hypoxic stress may become more invasive in a similar fashion.

Magnetic twisting cytometry (MTC) and atomic force microscopy have been employed previously to measure alterations in the mechanical properties of cancer cells in order to characterize the pathways responsible for actin reorganization19, 63,64,65. Stiffness of pulmonary microvascular endothelial cells exposed to hypoxia was measured using MTC. These investigators determined that hypoxia increased cell stiffness and therefore regulates endothelial cell contraction19. Cytoskeletal dynamics were measured in skin, bladder, prostate and kidney cancer cell lines. These results suggested that metastatic cancer cells exhibit increased localized cortical cell stiffness. This increased cell stiffness is required to facilitate the vascular invasion63,64,65. The mechanical response to the anticancer drugs colchicine or cytarabine exhibited by cervical and liver carcinoma cells were measured and these results demonstrated a correlation between the degree of mechanical changes in cells and the drug dosages63,64,65. Thus, employing MTC and atomic force microscopy could provide useful insights into cancer cell cytoskeletal dynamics, alterations and metastatic processes. Comparing the OT to other technologies, we find that its main advantage is being a noninvasive technique that can apply a uniform stress on cells that could aid in measuring cellular mechanical alterations more accurately. Our results demonstrate that the OT could be used to measure the mechanical properties of cells that correlate with cell migration. Thus, this technique could be used to evaluate drug candidates that target cell migration for their ability to alter those mechanical properties.

Our study suggests, that factors which regulate the hypoxic signals and thereby lead to the untoward activation of the ERK and AKT pathways, might be suitable therapeutic targets for prostate cancer metastasis, namely the HIF1 multi-protein transcriptional complex. Clinical trials of AKT and ERK inhibitors have demonstrated unacceptable toxicities66, 67 suggesting that targeting deregulated upstream factors may be more selective in treating prostate cancers. In conclusion, these results highlight the utility of the optical tweezer in characterizing the mechanical properties of cells, which might aid in identifying transformed cancer cells.

## Materials and Methods

### Materials and reagents

RGD peptide, wedelolactone, U0126 and A6730 were purchased from Sigma-Aldrich (ON, Canada). The microbeads were purchased from Bangs Laboratory (ON, Canada).

### Cell culture and exposure to hypoxia

The production of control shSCX- and knockdown shRb-LNCaP cells was described previously16. Cells were maintained in RPMI 1640 medium with L-Glutamine (BioWhittaker, Lonza), supplemented with 10% FBS and 1% 100 units/ml potassium penicillin- 100 μg/ml streptomycin sulphate. For hypoxia treatment, cells were placed into a humidified, hypoxia incubation chamber and maintained in 5% CO2, and 1% O2 at 37 °C. For normoxia treatment, cells were kept in a humidified incubation chamber and maintained at 37 °C with 5% CO2, and 20% O2.

### Quantitative Real-Time PCR

LNCaP cells were incubated under hypoxic conditions (1% O2) for 24 h in a humidified CO2 incubator. The mRNA levels of PLOD2 and 36B4 were determined using quantitative real-time PCR. The primer pairs for PLOD2 and 36B4 were described previously18, 68. Total RNA was isolated using TRI reagent (Sigma, Cat. No. T9424–200ML) according to the manufacturer’s protocol. Reverse transcription was performed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Part No.4368814) according to the manufacturer’s protocol. A total of 2 µg of RNA was used in a 20 µL reaction amplified by cycling between 25 °C for 5 min, 37 °C for 120 min, and 85 °C for 5 min (Veriti 96 Well Thermal Cycler, Applied Biosystems). For each experiment, a sample that was both infected with viral Rb-specific shRNA and pre-conditioned with hypoxia was used to generate a relative standard curve in which the sample was diluted 1:10 in five serial dilutions resulting in dilutions of 1:10, 1:100, 1:1,000, 1:10,000, and 1:100,000 whereas the samples were diluted 1:30; the analysis was done using StepOnePlus System (Applied Biosystems).

### Antibodies and immunoblotting

LNCaP cells were maintained under normal oxygen (normoxia, 20% O2) or incubated under hypoxic conditions (1% O2) for 24 h. Cells were then treated with either vehicle (DMSO) or drug (2 μM A6730 or 10 μM U0126) and then left at normoxia or hypoxia for a further 48 h. Cells were harvested and the protein concentration estimated by the RC DC Protein Assay (Bio-Rad). Equal amounts of total protein from the samples were resolved on a SDS-acrylamide gel then transferred to polyvinylidene fluoride (PVDF) membrane. Membranes were incubated with diluted primary antibodies in 5% w/v skim milk powder, 1X TBS, 0.1% Tween-20 at 4 °C with gentle shaking, overnight. Primary antibodies used were anti-α-tubulin (mouse monoclonal, Santa Cruz Biotechnology Inc., SC-8035), anti-pan-AKT (rabbit monoclonal, Cell Signalling Technology, 4691), anti-phospho-AKT (Ser473) (rabbit monoclonal antibody, Cell Signalling Technology, 4060), anti-phospho-AKT (Thr308) (rabbit monoclonal, Cell Signalling Technology, 13038), anti-p44/p42 (ERK1/2) 137F5 (rabbit monoclonal, Cell Signalling Technology, 4695), anti-phospho-p44/p42 MAPK (ERK1/2) (T202/Y204) (rabbit polyclonal, Cell Signalling Technologies, 9101), Rb (rabbit polyclonal, Santa Cruz Biotechnology, SC-7905) and pan-actin (rabbit polyclonal, Cell Signalling Technology, 4968). Horseradish peroxidase conjugated anti-mouse or anti-rabbit IgG (Santa Cruz Biotechnology Inc.) and Luminata Crescendo Western HRP substrate (EMD Millipore) were used for detection.

### Migration assay

Control scrambled or shRb LNCaP cells were conditioned with hypoxia (1% O2) or maintained at normoxic conditions and treated with either vehicle or drug (10 μM U0126, 2 μM A6730 or 10 nM INK128) for 96 h. After 96 h, cells were washed, trypsinized, counted on a Haemocytometer and then seeded on ThinCerts (Greiner Bio-One) with 8.0 μm pore size at 1 × 104 cells per cell culture insert. The cells were maintained in serum-free RPMI 1640 with L-glutamine in the upper chamber whereas the lower chamber contained RPMI 1640 media with L-glutamine and 50% FBS. Cells were treated as stated above for a further 72 h and then total migrating cells were counted using an Olympus CKX41 light microscope.

### Immunofluoresence analysis and confocal microscopy

Rb proficient and deficient LNCaP cells were seeded on poly-L-lysine coated coverslips in six-well plates. The next day, cells were treated with either DMSO, 10 μM U0126 or 2 μM A6701 and then exposed to 1% O2 or left at normoxia for 72 hours. Cells were fixed with 4% paraformaldehyde in PBS and then permeabilized with 0.1% Triton X-100 in PBS. Cells were blocked with 1% BSA in PBS for 30 minutes and then incubated with TRITC-conjugated Rhodamine phalloidin (Life Technologies) for 1 hour at room temperature. Cells were washed with PBS, counter stained with 4′,6-diamidino-2-phenylindole (DAPI) and then mounted on slides with FluorSave (Calbiochem). Cell morphology was observed using a Zeiss LSM 780 confocal microscope and 63X objective lens magnification. Each image was recorded using the same power, magnification and exposure settings and cells were imaged using ZEN software (ZEISS Microscopy).

For the double-blind analysis, images consisting of ≥50 cells for each treatment condition were collected under the same power, exposure and magnification. Image files were then encrypted and a skilled person familiar with cellular structures but blind to the treatments and the expected results used ImageJ software (V1.51k, National Institutes of Health, Bethesda, Maryland, USA) to analyze fluorescent measurements of cell-cell boundaries and filopodia-like actin processes. All RGB images were first converted to 8-bit gray scale images for the imageJ analysis. To analyze the actin fluorescence in cell-cell boundaries and filopodia-like processes, the Freehand tool was used to carefully enclose these structures in each image. Then, the minimum, the maximum, and the average fluorescent intensity within each defined area were recorded. The detailed measurements for each image as well as a summary of the results for different treatments can be found in the Supplementary Dataset Files 1 and 2 (“Double-Blind Measurements of Individual Images.xlsx” and “Double-Blind Summary of Each Treatment.xlsx” respectively).

### Oscillating optical tweezer mechanical characterization

The stiffness of shRNA LNCaP cells was measured using an oscillating OT as described previously26. Briefly, the OT experimental set up is composed of a 3 W continuous wave, Nd:YAG laser beam with a wavelength of 1064 nm. The Nikon TE2000 inverted microscope is employed and the laser beam is highly focused at the sample surface by a 100X objective. The tripeptide Arg-Gly-Asp (RGD)-coated microbeads bound to the cell surface were trapped by the laser tweezer and then moved back and forth via oscillating laser trap with various frequencies of 0.1, 1, 10 Hz. As the bead moves sinusoidally, the cell develops internal stress and resistance to the bead motion that depends on the cell’s mechanical properties. The resultant bead displacement in response to the force applied by the tweezer was measured optically and the bead motion equation was used to calculate the cell shear modulus and viscosity in the frequency domain. The NARBM is the normalized representation of the measured microbead’s displacement (x(t)) due to applied force and is described by equation (1):

$NARBM= x ( t ) r c o n t ,$
(1)

where rcont is the bead-cell contact radius (0.25~0.45 μm). More details about rcont can be found in ref. 26.

The cell relaxation time can also be measured by a microbead linked to a cell in viscous solution trapped by the OT. Movement of the trapped bead due to viscous drag force of the surrounding solution as well as the thermal noise of the laser causes a cell to develop an internal stress that also depends on the cell’s mechanical properties. The bead motion in response to such forces is measured and by performing autocorrelation analysis on the bead position signal, we can find the cell relaxation time as derived below.

### Data Analysis

In order to analyze the experimental data and calculate the changes in cell mechanical properties, a bead motion equation was used as described previously26. The cell relaxation time was calculated by measuring fluctuations in the position of trapped beads linked to the cell cytoskeleton. By analyzing the normalized position auto-correlation function of trapped bead signal fluctuations in time domain, relaxation time was determined. The trapped bead motion equation can be described by equation (2):

$x′+(1/ τ 0 )x=ξ(t),$
(2)
$τ 0 = ( γ + β ) k 1$$γ=6πa η m e d$$β= r c o n t η c e l l$

where x is position of fluctuating trapped bead, a is the bead radius (1.5 μm), η med is viscosity of surrounding media (10−3Pas), and ξ(t) is thermal white noise. η med and η cell are the viscosity coefficients of the surrounding medium and the cell structure, and k1 is the laser stiffness coefficient, and τ0 is the relaxation time. Integrating both sides of the above equation with respect to time, we arrived at equation (3):

$x ( t ) = e − t / τ 0 ∫ − ∞ t 1 ( γ + β ) ξ(τ′) e τ ′ τ 0 dτ′,$
(3)

Calculating the normalized position autocorrelation function, and using the statistical properties of ξ(t) which are described according to the Einstein diffusion equation, we arrived at equation (4):

$< ξ i ( t ) > = 0 < ξ i ( t ) ξ j ( t ′ ) > = 2 γ β k B T δ ( t − t ′ ) < x i ( t ) x i ( t + τ ) > = e − τ τ 0 ,$
(4)

where k B is Boltzmann constant (1.3806 × 10−23m2kgs−2K−1), and T is Room temperature (300 K).

Thus, by performing autocorrelation analysis on bead fluctuations and fitting the experimental results to the exponential function, we can determine the cell relaxation time

### Statistical analysis

For the optical tweezer experiments, qPCR and migration assays, all data are represented as means ± standard deviation (S.D.) and we used an ANOVA test for comparing more than two groups of samples’ means for statistical analysis. P < 0.05 was considered statistically significant. For the double blind analysis, we used a Kruskall-Wallis analysis with Dunn’s multiple comparisons test (alpha = 0.05; P-value < 0.05) to analyze mean pixel intensities along cell-cell boundaries. Statistical significance of the proportion of cells displaying filopodia-like clusters in each treatment group was determined using two-sided Fisher’s exact tests. All statistical analysis was conducted using GraphPad Prism software (GraphPad Software, Inc.).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## References

1. 1.

Chang, J. & Erler, J. Hypoxia-mediated metastasis. Adv Exp Med Biol 772, 55–81, doi:10.1007/978-1-4614-5915-6_3 (2014).

2. 2.

Subarsky, P. & Hill, R. P. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20, 237–250 (2003).

3. 3.

Yamaguchi, H. & Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773, 642–652, doi:10.1016/j.bbamcr.2006.07.001 (2007).

4. 4.

Gilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D. & Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. The Journal of biological chemistry 288, 10819–10829, doi:10.1074/jbc.M112.442939 (2013).

5. 5.

Gilkes, D. M. et al. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc Natl Acad Sci USA 111, E384–393, doi:10.1073/pnas.1321510111 (2014).

6. 6.

Park, J. E. et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9, 1085–1099, doi:10.1074/mcp.M900381-MCP200 (2010).

7. 7.

Vogel, S. et al. Prolyl hydroxylase domain (PHD) 2 affects cell migration and F-actin formation via RhoA/rho-associated kinase-dependent cofilin phosphorylation. J Biol Chem 285, 33756–33763, doi:10.1074/jbc.M110.132985 (2010).

8. 8.

Gonzalez-Mariscal, L., Tapia, R. & Chamorro, D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778, 729–756, doi:10.1016/j.bbamem.2007.08.018 (2008).

9. 9.

Lee, H. J. et al. Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1alpha, FASN, and mTORC1. Stem Cells 33, 2182–2195, doi:10.1002/stem.2020 (2015).

10. 10.

Ostergaard, L. et al. Proteomics reveals lowering oxygen alters cytoskeletal and endoplasmatic stress proteins in human endothelial cells. Proteomics 9, 4457–4467, doi:10.1002/pmic.200800130 (2009).

11. 11.

Veith, C. et al. Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: role of the cytoskeletal protein cofilin in pulmonary hypertension. Proteomics 13, 75–88, doi:10.1002/pmic.201200206 (2013).

12. 12.

Vogler, M. et al. Hypoxia modulates fibroblastic architecture, adhesion and migration: a role for HIF-1alpha in cofilin regulation and cytoplasmic actin distribution. PLoS One 8, e69128, doi:10.1371/journal.pone.0069128 (2013).

13. 13.

Labrecque, M. P., Prefontaine, G. G. & Beischlag, T. V. The aryl hydrocarbon receptor nuclear translocator (ARNT) family of proteins: transcriptional modifiers with multi-functional protein interfaces. Current molecular medicine 13, 1047–1065 (2013).

14. 14.

Chan, D. A. & Giaccia, A. J. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26, 333–339, doi:10.1007/s10555-007-9063-1 (2007).

15. 15.

Tsai, Y. P. & Wu, K. J. Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci 19, 102, doi:10.1186/1423-0127-19-102 (2012).

16. 16.

Labrecque, M. P. et al. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells. Oncotarget 7, 24284–24302, doi:10.18632/oncotarget.8301 (2016).

17. 17.

Beischlag, T. V. et al. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. The Journal of biological chemistry 279, 54620–54628, doi:10.1074/jbc.M410456200 (2004).

18. 18.

Labrecque, M. P. et al. A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1alpha-mediated transcription and cancer cell invasion. PloS one 9, e99214, doi:10.1371/journal.pone.0099214 (2014).

19. 19.

An, S. S. et al. Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways. Am J Physiol Cell Physiol 289, C521–530, doi:10.1152/ajpcell.00429.2004 (2005).

20. 20.

Hayashi, H., Tsuchiya, Y., Nakayama, K., Satoh, T. & Nishida, E. Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling. Genes Cells 13, 941–947, doi:10.1111/j.1365-2443.2008.01218.x (2008).

21. 21.

Roskoski, R. Jr. MEK1/2 dual-specificity protein kinases: structure and regulation. Biochemical and biophysical research communications 417, 5–10, doi:10.1016/j.bbrc.2011.11.145 (2012).

22. 22.

Choi, C. & Helfman, D. M. The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2. Oncogene 33, 3668–3676, doi:10.1038/onc.2013.341 (2014).

23. 23.

Irie, H. Y. et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171, 1023–1034, doi:10.1083/jcb.200505087 (2005).

24. 24.

Zhou, H. & Huang, S. Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci 12, 30–42 (2011).

25. 25.

Laplante, M. & Sabatini, D. M. mTOR signaling at a glance. J Cell Sci 122, 3589–3594, doi:10.1242/jcs.051011 (2009).

26. 26.

Khakshour, S., Beischlag, T. V., Sparrey, C. & Park, E. J. Probing mechanical properties of Jurkat cells under the effect of ART using oscillating optical tweezers. PloS one 10, e0126548, doi:10.1371/journal.pone.0126548 (2015).

27. 27.

An, S. S. et al. Role of heat shock protein 27 in cytoskeletal remodeling of the airway smooth muscle cell. Journal of applied physiology 96, 1701–1713, doi:10.1152/japplphysiol.01129.2003 (2004).

28. 28.

Bursac, P. et al. Cytoskeleton dynamics: fluctuations within the network. Biochemical and biophysical research communications 355, 324–330, doi:10.1016/j.bbrc.2007.01.191 (2007).

29. 29.

Bursac, P. et al. Cytoskeletal remodelling and slow dynamics in the living cell. Nature materials 4, 557–561, doi:10.1038/nmat1404 (2005).

30. 30.

Raupach, C. et al. Stress fluctuations and motion of cytoskeletal-bound markers. Physical review. E, Statistical, nonlinear, and soft matter physics 76, 011918, doi:10.1103/PhysRevE.76.011918 (2007).

31. 31.

Bausch, A. R., Ziemann, F., Boulbitch, A. A., Jacobson, K. & Sackmann, E. Local measurements of viscoelastic parameters of adherent cell surfaces by magnetic bead microrheometry. Biophys J 75, 2038–2049, doi:10.1016/S0006-3495(98)77646-5 (1998).

32. 32.

Docheva, D., Padula, D., Schieker, M. & Clausen-Schaumann, H. Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells. Biochem Biophys Res Commun 402, 361–366, doi:10.1016/j.bbrc.2010.10.034 (2010).

33. 33.

Ruoslahti, E. RGD and other recognition sequences for integrins. Annual review of cell and developmental biology 12, 697–715, doi:10.1146/annurev.cellbio.12.1.697 (1996).

34. 34.

Soni, G. V., Ali, B. M., Hatwalne, Y. & Shivashankar, G. V. Single particle tracking of correlated bacterial dynamics. Biophys J 84, 2634–2637 (2003).

35. 35.

Bardos, J. I. & Ashcroft, M. Hypoxia-inducible factor-1 and oncogenic signalling. BioEssays: news and reviews in molecular, cellular and developmental biology 26, 262–269, doi:10.1002/bies.20002 (2004).

36. 36.

Minet, E., Michel, G., Mottet, D., Raes, M. & Michiels, C. Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free radical biology & medicine 31, 847–855 (2001).

37. 37.

Fan, Z. et al. Role of the PI3K/AKT pathway in modulating cytoskeleton rearrangements and phenotype switching in rat pulmonary arterial vascular smooth muscle cells. DNA Cell Biol 33, 12–19, doi:10.1089/dna.2013.2022 (2014).

38. 38.

Gan, Y. et al. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29, 4947–4958, doi:10.1038/onc.2010.240 (2010).

39. 39.

Dworakowska, D. et al. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16, 1329–1338, doi:10.1677/ERC-09-0101 (2009).

40. 40.

Edwards, M. W. et al. Role of mTOR downstream effector signaling molecules in Francisella tularensis internalization by murine macrophages. PLoS One 8, e83226, doi:10.1371/journal.pone.0083226 (2013).

41. 41.

Mattila, P. K. & Lappalainen, P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9, 446–454, doi:10.1038/nrm2406 (2008).

42. 42.

Mavrommati, I., Cisse, O., Falasca, M. & Maffucci, T. Novel roles for class II Phosphoinositide 3-Kinase C2beta in signalling pathways involved in prostate cancer cell invasion. Sci Rep 6, 23277, doi:10.1038/srep23277 (2016).

43. 43.

Logue, J. S. et al. Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration. eLife 4, e08314, doi:10.7554/eLife.08314 (2015).

44. 44.

Aggarwal, S., Singh, M., Kumar, A. & Mukhopadhyay, T. SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization. Mol Cell Biochem 408, 15–23, doi:10.1007/s11010-015-2478-z (2015).

45. 45.

Ahn, Y. T. et al. Counteracting the activation of pAkt by inhibition of MEK/Erk inhibition reduces actin disruption-mediated apoptosis in PTEN-null PC3M prostate cancer cell lines. Oncol Lett 6, 1383–1389, doi:10.3892/ol.2013.1547 (2013).

46. 46.

Pawlak, G. & Helfman, D. M. MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J Biol Chem 277, 26927–26933, doi:10.1074/jbc.M202261200 (2002).

47. 47.

Singh, A. R., Joshi, S., George, E. & Durden, D. L. Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model. Cancer Cell Int 14, 105, doi:10.1186/s12935-014-0105-9 (2014).

48. 48.

Xu, F., Ito, S., Hamaguchi, M. & Senga, T. Disruption of cell spreading by the activation of MEK/ERK pathway is dependent on AP-1 activity. Nagoya J Med Sci 72, 139–144 (2010).

49. 49.

Wang, T. C., Luo, S. J., Lin, C. L., Chang, P. J. & Chen, M. F. Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells. Clinical & experimental metastasis 32, 73–81, doi:10.1007/s10585-014-9692-z (2015).

50. 50.

Kidd, M. E., Shumaker, D. K. & Ridge, K. M. The role of vimentin intermediate filaments in the progression of lung cancer. American journal of respiratory cell and molecular biology 50, 1–6, doi:10.1165/rcmb.2013-0314TR (2014).

51. 51.

Liang, Z. W. et al. Nestin-mediated cytoskeletal remodeling in endothelial cells: novel mechanistic insight into VEGF-induced cell migration in angiogenesis. Am J Physiol Cell Physiol 308, C349–358, doi:10.1152/ajpcell.00121.2014 (2015).

52. 52.

Yu, S. et al. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression. Oncotarget 6, 2951–2965, doi:10.18632/oncotarget.3095 (2015).

53. 53.

Chen, D. et al. Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration. Scientific reports 5, 16813, doi:10.1038/srep16813 (2015).

54. 54.

Niba, E. T. et al. Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 31, 905–913, doi:10.1159/000350108 (2013).

55. 55.

Yu, C. F., Liu, Z. X. & Cantley, L. G. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 277, 19382–19388, doi:10.1074/jbc.M200732200 (2002).

56. 56.

Moelling, K., Schad, K., Bosse, M., Zimmermann, S. & Schweneker, M. Regulation of Raf-Akt Cross-talk. J Biol Chem 277, 31099–31106, doi:10.1074/jbc.M111974200 (2002).

57. 57.

Kodaki, T. et al. The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 4, 798–806 (1994).

58. 58.

Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21–35, doi:10.1038/nrm3025 (2011).

59. 59.

Cho, S. G. et al. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res 71, 6535–6546, doi:10.1158/0008-5472.CAN-11-0329 (2011).

60. 60.

Cvetkovic, D. et al. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. Endocrinology 154, 1999–2014, doi:10.1210/en.2012-2164 (2013).

61. 61.

Pampillo, M. et al. Regulation of GPR54 signaling by GRK2 and {beta}-arrestin. Mol Endocrinol 23, 2060–2074, doi:10.1210/me.2009-0013 (2009).

62. 62.

Goertzen, C. G., Dragan, M., Turley, E., Babwah, A. V. & Bhattacharya, M. KISS1R signaling promotes invadopodia formation in human breast cancer cell via beta-arrestin2/ERK. Cellular signalling 28, 165–176, doi:10.1016/j.cellsig.2015.12.010 (2016).

63. 63.

Coughlin, M. F. & Fredberg, J. J. Changes in cytoskeletal dynamics and nonlinear rheology with metastatic ability in cancer cell lines. Phys Biol 10, 065001, doi:10.1088/1478-3975/10/6/065001 (2013).

64. 64.

Hesse, A. R. et al. Lights on for HIF-1alpha: genetically enhanced mouse cardiomyocytes for heart tissue imaging. Cell Physiol Biochem 34, 455–462, doi:10.1159/000363014 (2014).

65. 65.

Wang, J. et al. Atomic force microscope study of tumor cell membranes following treatment with anti-cancer drugs. Biosens Bioelectron 25, 721–727, doi:10.1016/j.bios.2009.08.011 (2009).

66. 66.

Dreaden, E. C. et al. Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle. Clin Cancer Res 21, 4410–4419, doi:10.1158/1078-0432.CCR-15-0013 (2015).

67. 67.

Vogel, C. J. et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res 28, 307–317, doi:10.1111/pcmr.12364 (2015).

68. 68.

Wang, F. et al. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. The Journal of biological chemistry 279, 46733–46741, doi:10.1074/jbc.M409002200 (2004).

## Acknowledgements

This work was supported by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to T.V.B. and E.J.P.

## Author information

### Author notes

1. S. Khakshour and M. P. Labrecque contributed equally to this work.

### Affiliations

1. #### School of Mechatronic Systems Engineering, Faculty of Applied Sciences, Simon Fraser University, Surrey, BC, Canada

• S. Khakshour
• , H. Esmaeilsabzali
•  & E. J. Park
2. #### Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada

• M. P. Labrecque
• , F. J. S. Lee
• , E. J. Park
•  & T. V. Beischlag

• M. E. Cox

### Contributions

S.K. and M.P.L. contributed equally to this work. S.K. performed all optical tweezer experiments and wrote a large portion of the paper. M.P.L. performed all immunoblots, qRT-PCR, immunofluorescence experiments and confocal microscopy. M.P.L. also wrote the methods, results and discussion for this part of the report. H.E. conducted the double blind analysis of the immunofluorescence images. F.J.S.L. and M.E.C. assisted with the experimental design and microscopy. E.P. aided in the experimental design, writing and editing. T.V.B. performed cell migration assays and contributed to the experimental design and to the writing, and editing.

### Competing Interests

The authors declare that they have no competing interests.

### Corresponding authors

Correspondence to E. J. Park or T. V. Beischlag.